Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Tumbleweed67on Aug 01, 2009 1:13pm
566 Views
Post# 16184597

RE: RE: RE: RE: News on Tuesday???

RE: RE: RE: RE: News on Tuesday???investorplus,

I sure hope you are right, and tend to believe you are close. However, I think this SP is (barely) being propped up by the expectation that something large is imminent. If this turns out to be a giant blunder by management, ie. that the recent NR were what they expected to boost the SP, and we go a few weeks without anything else, you might just be adding to you holdings for a dime again.

Let's hope not!

TW
Bullboard Posts